Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313579642> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4313579642 endingPage "141" @default.
- W4313579642 startingPage "136" @default.
- W4313579642 abstract "Objectives: There are currently no appropriate markers and target for prophylaxis against COVID-19-related thrombosis, especially in the not-severe cases. We tested the hypothesis that inflammation is a suitable marker and target for prophylaxis against COVID-19-related thrombosis. Methods: Data of all 32 COVID-19 patients admitted to Saitama Medical Center between January 1 and March 30, 2021, were analyzed. Patients were divided into severe (requiring oxygen, n=12) and non-severe (no requirement for oxygen, n=20), and also those with high C-reactive protein (CRP) level (cutoff value: 30 mg/L, n=21) and low-CRP (n=11). We also compared the clinical and laboratory data of a 46-year-old post-liver transplant male patient, who was treated with a combination of immunosuppressants (methylprednisolone, fludrocortisone, cyclosporine, and everolimus) with those of other COVID-19 patients, using the Smirnoff-Grubbs and Box plots tests. Results: The levels of CRP, ferritin, lactate dehydrogenase, aspartate aminotransferase, and thrombin-antithrombin complex (TAT) were significantly higher in the high-severity group than the low-severity group; while other coagulation parameters were comparable. The time between onset of illness and blood levels of lactate dehydrogenase, fibrinogen, D-dimer, TAT, and plasmin alpha2-plasmin inhibitor complex (PIC) were significantly higher whereas lymphocyte count was significantly lower in the high-CRP group. Extremely low levels of TAT, PIC, and plasminogen activator inhibitor-1 (PAI-1) were recorded in the liver transplant patient treated with immunosuppressants. The TAT, PIC, and PAI-1 levels were deemed outliers. Conclusions: Inflammation is a potentially suitable marker and target for prophylaxis against COVID-19-related thrombosis." @default.
- W4313579642 created "2023-01-06" @default.
- W4313579642 creator A5026520913 @default.
- W4313579642 creator A5042440134 @default.
- W4313579642 creator A5053477873 @default.
- W4313579642 creator A5067290436 @default.
- W4313579642 creator A5067506104 @default.
- W4313579642 creator A5073761759 @default.
- W4313579642 date "2023-01-01" @default.
- W4313579642 modified "2023-10-14" @default.
- W4313579642 title "Inflammation as an exacerbation marker and target for prophylaxis against Coronavirus Disease 2019-related thrombosis" @default.
- W4313579642 cites W191300012 @default.
- W4313579642 cites W2034413738 @default.
- W4313579642 cites W2134766532 @default.
- W4313579642 cites W2338749364 @default.
- W4313579642 cites W3012405893 @default.
- W4313579642 cites W3017343267 @default.
- W4313579642 cites W3038750665 @default.
- W4313579642 cites W3046396978 @default.
- W4313579642 cites W3082355253 @default.
- W4313579642 cites W3113196149 @default.
- W4313579642 cites W3159129726 @default.
- W4313579642 cites W3172155398 @default.
- W4313579642 cites W3206483794 @default.
- W4313579642 cites W3213860519 @default.
- W4313579642 cites W4283796992 @default.
- W4313579642 doi "https://doi.org/10.7150/ijms.78911" @default.
- W4313579642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36619223" @default.
- W4313579642 hasPublicationYear "2023" @default.
- W4313579642 type Work @default.
- W4313579642 citedByCount "0" @default.
- W4313579642 crossrefType "journal-article" @default.
- W4313579642 hasAuthorship W4313579642A5026520913 @default.
- W4313579642 hasAuthorship W4313579642A5042440134 @default.
- W4313579642 hasAuthorship W4313579642A5053477873 @default.
- W4313579642 hasAuthorship W4313579642A5067290436 @default.
- W4313579642 hasAuthorship W4313579642A5067506104 @default.
- W4313579642 hasAuthorship W4313579642A5073761759 @default.
- W4313579642 hasBestOaLocation W43135796421 @default.
- W4313579642 hasConcept C126322002 @default.
- W4313579642 hasConcept C203014093 @default.
- W4313579642 hasConcept C2776825266 @default.
- W4313579642 hasConcept C2776914184 @default.
- W4313579642 hasConcept C2779036427 @default.
- W4313579642 hasConcept C2779519742 @default.
- W4313579642 hasConcept C2779679481 @default.
- W4313579642 hasConcept C2780868729 @default.
- W4313579642 hasConcept C2781195455 @default.
- W4313579642 hasConcept C71924100 @default.
- W4313579642 hasConcept C90924648 @default.
- W4313579642 hasConceptScore W4313579642C126322002 @default.
- W4313579642 hasConceptScore W4313579642C203014093 @default.
- W4313579642 hasConceptScore W4313579642C2776825266 @default.
- W4313579642 hasConceptScore W4313579642C2776914184 @default.
- W4313579642 hasConceptScore W4313579642C2779036427 @default.
- W4313579642 hasConceptScore W4313579642C2779519742 @default.
- W4313579642 hasConceptScore W4313579642C2779679481 @default.
- W4313579642 hasConceptScore W4313579642C2780868729 @default.
- W4313579642 hasConceptScore W4313579642C2781195455 @default.
- W4313579642 hasConceptScore W4313579642C71924100 @default.
- W4313579642 hasConceptScore W4313579642C90924648 @default.
- W4313579642 hasIssue "1" @default.
- W4313579642 hasLocation W43135796421 @default.
- W4313579642 hasLocation W43135796422 @default.
- W4313579642 hasLocation W43135796423 @default.
- W4313579642 hasOpenAccess W4313579642 @default.
- W4313579642 hasPrimaryLocation W43135796421 @default.
- W4313579642 hasRelatedWork W1967164403 @default.
- W4313579642 hasRelatedWork W1980827916 @default.
- W4313579642 hasRelatedWork W2022271901 @default.
- W4313579642 hasRelatedWork W2269334624 @default.
- W4313579642 hasRelatedWork W2315834464 @default.
- W4313579642 hasRelatedWork W2348009661 @default.
- W4313579642 hasRelatedWork W2355504407 @default.
- W4313579642 hasRelatedWork W2417980370 @default.
- W4313579642 hasRelatedWork W2581241443 @default.
- W4313579642 hasRelatedWork W3018241306 @default.
- W4313579642 hasVolume "20" @default.
- W4313579642 isParatext "false" @default.
- W4313579642 isRetracted "false" @default.
- W4313579642 workType "article" @default.